All
FDA Approves Rozlytrek to Treat Certain Patients With an NTRK Gene Fusion and NSCLC
August 16th 2019The Food and Drug Administration approved Rozlytrek (entrectinib) for adult and adolescent patients 12 years of age and older whose cancers have the NTRK gene fusion and for adults with non-small cell lung cancer whose tumors are ROS1-positive and have spread to other parts of the body.
Caregivers: Finding the Support and Resources You Need
August 13th 2019In order to best care for someone else, you need to take care of yourself. If you are caring for a loved one undergoing breast cancer treatment, there is support you can turn to. In this article, you’ll find some helpful tips and resources in order to be better-equipped as a caregiver.
Live Into Your Life: A Q&A with Melissa Surdez, Metastatic Liver and IMPACT Luncheon Speaker
August 9th 2019Melissa Surdez truly is a liver. She dives headfirst into living and loving life with positivity, enthusiasm and true happiness. As a woman living with metastatic breast cancer, Melissa is an encouraging inspiration to many.